Yize Mao
Impact in
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- COVID-19 and healthcare impacts
- Cancer survivorship and care
- Cancer Cells and Metastasis
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
Papers in
- Co-authors
- Zikun Ma (5 shared papers)Zhuowei Liu (5 shared papers)Shengping Li (8 shared papers)Chaobin He (10 shared papers)Shengping Li (15 shared papers)Xin Huang (6 shared papers)Wei Chen (2 shared papers)Runsen Chen (2 shared papers)
- Journals
- Nature Communications (3 papers)European Radiology (3 papers)Cancer Medicine (3 papers)Journal of Gastrointestinal Surgery (2 papers)Research (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yize Mao
35 papers receiving 864 citations
Yize Mao's Hit Papers
Peers
Comparison fields: 5 of 87
- Oncology 537
- Cancer Research 113
- Immunology 133
- Clinical Psychology 113
- Surgery 234
Countries citing papers authored by Yize Mao
This map shows the geographic impact of Yize Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yize Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yize Mao more than expected).
Fields of papers citing papers by Yize Mao
This network shows the impact of papers produced by Yize Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yize Mao. The network helps show where Yize Mao may publish in the future.
Co-authors
The 25 scholars most cited alongside Yize Mao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 200 | |
| 2 | Interferon-dependent SLC14A1+ cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer Hit paper breakdown → | 2022 | 146 |
| 3 | 2016 | 69 | |
| 4 | 2020 | 59 | |
| 5 | 2018 | 38 | |
| 6 | 2018 | 32 | |
| 7 | 2023 | 30 | |
| 8 | 2020 | 30 | |
| 9 | 2018 | 28 | |
| 10 | 2017 | 23 | |
| 11 | 2020 | 19 | |
| 12 | 2017 | 19 | |
| 13 | 2020 | 16 | |
| 14 | 2018 | 16 | |
| 15 | 2018 | 15 | |
| 16 | 2016 | 15 | |
| 17 | 2024 | 14 | |
| 18 | 2020 | 14 | |
| 19 | 2023 | 13 | |
| 20 | 2018 | 12 |
About Yize Mao
Yize Mao is a scholar working on Oncology, Surgery, Immunology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 40 papers that have together received 874 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (16 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Radiomics and Machine Learning in Medical Imaging (7 papers), Inflammatory Biomarkers in Disease Prognosis (6 papers), Pancreatitis Pathology and Treatment (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Neuroendocrine Tumor Research Advances (4 papers) and Immune cells in cancer (4 papers). The work is most often cited by research in Oncology (537 citations), Cancer Research (113 citations), Immunology (133 citations), Clinical Psychology (113 citations) and Surgery (234 citations). Yize Mao has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zikun Ma, Zhuowei Liu, Shengping Li, Chaobin He, Shengping Li, Xin Huang, Wei Chen, Runsen Chen, Guo‐He Lin and Zhizhou Duan. Their work appears in journals such as Nature Communications, European Radiology, Cancer Medicine, Journal of Gastrointestinal Surgery and Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.